¹⁸F-fluorodeoxyglucose positron emission tomography/computed tomography in diagnosis of post-transplant lymphoproliferative disorder

References

• Burns D, Crawford D. Epstein-Barr virus-specific cytotoxic T-lymphocytes for adoptive immunotherapy of post-transplant lymphoproliferative disease. Blood Rev 2004;18:193–209.
   PubMed Web of Science ®Google Scholar
• Feng S, Buell JF, Chari RS, et al. Tumors and transplantation: the 2003 third annual ASTS State-of-the-Art Winter Symposium. Am J Transplant 2003;3:1481–1487.
   PubMed Web of Science ®Google Scholar
• Leblond V, Davi F, Charlotte F, et al. Posttransplant lymphoproliferative disorders not associated with Epstein-Barr virus: a distinct entity?. J Clin Oncol 1998;16:2052–2059.
   PubMed Web of Science ®Google Scholar
• Newell K, Alonso E, Whitington P, et al. Posttransplant lymphoproliferative disease in pediatric liver transplantation. Interplay between primary Epstein-Barr virus infection and immunosuppression. Transplantation 1996;62:370–375.
   Google Scholar
• Opelz G, Döhler B. Lymphomas after solid organ transplantation: a collaborative transplant study report. Am J Transplant 2004;4:222–230.
   PubMed Web of Science ®Google Scholar
• Dierickx D, Tousseyn T, Sagaert X, et al. Single-center analysis of biopsy-confirmed posttransplant lymphoproliferative disorder: incidence, clinicopathological characteristics and prognostic factors. Leuk Lymphoma 2013 Apr 9. [Epub ahead of print]
   Web of Science ®Google Scholar
• Parker A, Amlot P, Bowles K, et al. Guidelines on the surveillance, diagnosis and management of post-transplant lymphoproliferative disorders in adult solid organ transplant recipients. Available from: http://www.bcshguidelines.com/pdf/pltd_finaldraft_071009.pdf. 2009
   Google Scholar
• Carr R, Barrington SF, Madan B, et al. Detection of lymphomas in bone marrow by whole-body positron emission tomography. Blood 1998;91:3340–3346.
   PubMed Web of Science ®Google Scholar
• Juweid ME, Cheson BD. Positron-emission tomography and assessment of cancer therapy. N Engl J Med 2006;354:496–507.
   PubMed Web of Science ®Google Scholar
• Juweid ME, Stroobants S, Hoekstra OS, et al. Use of positron emission tomography for response assessment of lymphoma: consensus of the Imaging Subcommittee of the International Harmonization Project in Lymphoma. J Clin Oncol 2007;25:571–578.
   PubMed Web of Science ®Google Scholar
• Pan MH, Chang YL, Wu YW, et al. Gallium-67 scintigraphy and F-18 fluorodeoxyglucose positron emission tomography in posttransplant lymphoproliferative disorder. Clin Nucl Med 2004;29:329–331.
   PubMed Web of Science ®Google Scholar
• Tamai K, Koyama T, Saga T, et al. Posttransplant lymphoproliferative disorder in a lung transplant recipient. J Thorac Imaging 2005;20:280–283.
   PubMed Web of Science ®Google Scholar
• Marom E, McAdams HP, Butnor K, et al. Positron emission tomography with fluoro-2-deoxy-D-glucose (FDG-PET) in the staging of posttransplant lymphomproliferative disorder in lung transplant recipients. J Thorac Imaging 2004;19:74–78.
   PubMed Web of Science ®Google Scholar
• O’Conner AR, Franc BL. F-FDG PET imaging in the evaluation of post-transplant lymphoproliferative disorder following renal transplantation. Nucl Med Commun 2005:26:1107–1111.
   PubMed Web of Science ®Google Scholar
• Von Falck C, Maecker B, Schirg E, et al. Post transplant lymphoproliferative disease in pediatric solid organ transplant patients: a possible role for [18F]-F-FDG-PET/CT in initial staging and therapy monitoring. Eur J Radiol 2007:63:427–435.
   PubMed Web of Science ®Google Scholar
• McCormack L, Hany T, Hubner M, et al. How useful is PET/CT imaging in the management of post-transplant lymphoproliferative disease after liver transplantation?. Am J Transplant 2006;6:1731–1736.
   PubMed Web of Science ®Google Scholar
• Tulpule S, Mikhaeel G, Kazmi M, et al. B cell post transplant lymphoproliferative disorder complicating solid organ transplantation (B-PTLD): a single centre review reporting 1) results with chemo-immunotherapy (CHOP/R) and 2) the predictive ability of F-FDG-PET scanning to correlate with long term overall survival. Blood 2005;106(Suppl. 1): Abstract 1500.
   Web of Science ®Google Scholar
• Bakker N, Pruim J, de Graaf W, et al. PTLD visualization by F-FDG-PET: improved detection of extranodal localizations. Am J Transplant 2006;6:1984–1985.
   PubMed Web of Science ®Google Scholar
• Bianchi E, Pascual M, Nicod M, et al. Clinical usefulness of F-FDG-PET/CT scan imaging in the management of posttransplant lymphoproliferative disease. Transplantation 2008;85:707–712.
   PubMed Web of Science ®Google Scholar
• Blaes A, Cioc A, Froelich J, et al. Positron emission tomography scanning in the setting of post-transplant lymphoproliferative disorders. Clin Transplant 2009;23:794–799.
   PubMed Web of Science ®Google Scholar
• Dierickx D, Tousseyn T, Requile A, et al. The accuracy of positron emission tomographyin the detection of posttransplant lymphoproliferative disorder. Haematologica 2013;98:771–775.
   PubMed Web of Science ®Google Scholar
• Dummer JS, Bound LM, Singh G, et al. Epstein–Barr virus induced lymphoma in a cardiac transplant patient. Am J Med 1984;77: 179–184.
   PubMed Web of Science ®Google Scholar
• Murray JE, Wilson RE, Tilney NL, et al. Five years’ experience in renal transplantation with immunosuppressive drugs: survival, function, complications, and the role of lymphocyte depletion by thoracic duct fistula. Ann Surg 1968;168:416–435.
   PubMed Web of Science ®Google Scholar
• Penn I, Hammond W, Brettschneider L, et al. Malignant lymphomas in transplantation patients. Transplant Proc 1969;1:106–112.
   PubMed Web of Science ®Google Scholar
• Ghobrial IM, Habermann TM, Maurer MJ, et al. Prognostic analysis for survival in adult solid organ transplant recipients with post-transplantation lymphoproliferative disorders. J Clin Oncol. 2005;23:7574–7582.
   PubMed Web of Science ®Google Scholar
• Bustami RT, Ojo AO, Wolfe RA, et al. Immunosuppression and the risk of post-transplant malignancy among cadaveric first kidney transplant recipients. Am J Transplant 2004;4:87–93.
   PubMed Web of Science ®Google Scholar
• Caillard S, Dharnidharka V, Agodoa L, et al. Posttransplant lymphoproliferative disorders after renal transplantation in the United States in era of modern immunosuppression. Transplantation 2005;80:1233–1243.
   PubMed Web of Science ®Google Scholar